NOVAVAX INC Investing Cash Flow
NOVAVAX INC (NVAX) reported Investing Cash Flow of $6.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- NOVAVAX INC net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $34.90M, a 68.59% decline year-over-year.
- NOVAVAX INC net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$28.36M.
- NOVAVAX INC net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $20.48M, a 85.78% decline year-over-year.
- NOVAVAX INC net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$136.53M, a 527.83% decline year-over-year.
- NOVAVAX INC net cash provided by (used in) investing activities for fiscal 2025 was -$78.27M.
- NOVAVAX INC net cash provided by (used in) investing activities for fiscal 2024 was -$204.04M.
- NOVAVAX INC net cash provided by (used in) investing activities for fiscal 2023 was -$58.81M.
- NOVAVAX INC net cash provided by (used in) investing activities for fiscal 2022 was -$92.98M, a 192.84% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $34.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.54M 10-Q · filed 2026-08-06 | $27.02M derived: sum of 3 quarters · filed 2026-08-06 | -$109.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$28.36M 10-Q · filed 2026-05-06 | -$7.88M derived: sum of 2 quarters · filed 2026-05-06 | -$144.41M derived: sum of 3 quarters · filed 2026-05-06 | -$33.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $20.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$116.05M derived: sum of 2 quarters · filed 2026-02-26 | -$4.95M derived: sum of 3 quarters · filed 2026-08-06 | -$78.27M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$136.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$25.43M derived: sum of 2 quarters · filed 2026-08-06 | -$98.75M 10-Q · filed 2025-11-06 | $45.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $111.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $37.78M 10-Q · filed 2026-08-06 | $181.79M derived: sum of 3 quarters · filed 2026-08-06 | $213.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$73.32M 10-Q · filed 2026-05-06 | $70.69M derived: sum of 2 quarters · filed 2026-05-06 | $102.60M derived: sum of 3 quarters · filed 2026-05-06 | -$270.11M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $144.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $175.92M derived: sum of 2 quarters · filed 2026-02-26 | -$196.79M derived: sum of 3 quarters · filed 2026-02-26 | -$204.04M 10-K · filed 2026-02-26 |
| 2024-09-30 | $31.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$340.80M derived: sum of 2 quarters · filed 2025-11-06 | -$348.05M 10-Q · filed 2025-11-06 | -$357.12M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$372.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$379.96M 10-Q · filed 2025-08-06 | -$389.04M derived: sum of 3 quarters · filed 2026-02-26 | -$407.43M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$7.25M 10-Q · filed 2025-05-08 | -$16.33M derived: sum of 2 quarters · filed 2026-02-26 | -$34.72M derived: sum of 3 quarters · filed 2026-02-26 | -$42.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$9.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$27.47M derived: sum of 2 quarters · filed 2026-02-26 | -$35.25M derived: sum of 3 quarters · filed 2026-02-26 | -$58.81M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$18.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$26.17M derived: sum of 2 quarters · filed 2024-11-12 | -$49.73M 10-Q · filed 2024-11-12 | -$71.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$7.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$31.34M 10-Q · filed 2024-08-08 | -$53.40M derived: sum of 3 quarters · filed 2025-02-27 | -$82.92M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$23.56M 10-Q · filed 2024-05-10 | -$45.62M derived: sum of 2 quarters · filed 2025-02-27 | -$75.14M derived: sum of 3 quarters · filed 2025-02-27 | -$99.72M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$22.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$51.58M derived: sum of 2 quarters · filed 2025-02-27 | -$76.16M derived: sum of 3 quarters · filed 2025-02-27 | -$92.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$29.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$54.09M derived: sum of 2 quarters · filed 2023-11-09 | -$70.92M 10-Q · filed 2023-11-09 | -$87.28M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$24.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$41.40M 10-Q · filed 2023-08-08 | -$57.77M derived: sum of 3 quarters · filed 2024-02-28 | -$69.96M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$16.83M 10-Q · filed 2023-05-09 | -$33.19M derived: sum of 2 quarters · filed 2024-02-28 | -$45.38M derived: sum of 3 quarters · filed 2024-02-28 | -$58.28M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$16.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$28.55M derived: sum of 2 quarters · filed 2024-02-28 | -$41.45M derived: sum of 3 quarters · filed 2024-02-28 | $100.15M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$12.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$25.09M derived: sum of 2 quarters · filed 2022-11-09 | $116.52M 10-Q · filed 2022-11-09 | $85.40M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$12.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $128.71M 10-Q · filed 2022-08-09 | $97.59M derived: sum of 3 quarters · filed 2023-02-28 | -$3.12M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $141.61M 10-Q · filed 2022-05-10 | $110.49M derived: sum of 2 quarters · filed 2023-02-28 | $9.78M derived: sum of 3 quarters · filed 2023-02-28 | -$178.44M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$31.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$131.83M derived: sum of 2 quarters · filed 2023-02-28 | -$320.05M derived: sum of 3 quarters · filed 2023-02-28 | -$377.78M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$100.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$288.93M derived: sum of 2 quarters · filed 2021-11-05 | -$346.66M 10-Q · filed 2021-11-05 | -$346.87M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$188.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$245.95M 10-Q · filed 2021-08-05 | -$246.16M derived: sum of 3 quarters · filed 2022-03-01 | -$228.19M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$57.73M 10-Q · filed 2021-05-10 | -$57.94M derived: sum of 2 quarters · filed 2022-03-01 | -$39.97M derived: sum of 3 quarters · filed 2022-03-01 | -$37.95M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $17.76M derived: sum of 2 quarters · filed 2022-03-01 | $19.78M derived: sum of 3 quarters · filed 2022-03-01 | $38.49M 10-K · filed 2022-03-01 |
| 2019-09-30 | $17.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $20.00M derived: sum of 2 quarters · filed 2020-11-10 | $38.71M 10-Q · filed 2020-11-10 | $87.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $20.73M 10-Q · filed 2020-08-10 | $69.05M derived: sum of 3 quarters · filed 2021-03-01 | $77.05M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $18.71M 10-Q · filed 2020-05-11 | $67.03M derived: sum of 2 quarters · filed 2021-03-01 | $75.03M derived: sum of 3 quarters · filed 2021-03-01 | $26.72M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $48.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $56.31M derived: sum of 2 quarters · filed 2021-03-01 | $8.01M derived: sum of 3 quarters · filed 2021-03-01 | $28.60M 10-K · filed 2021-03-01 |
| 2018-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$40.31M derived: sum of 2 quarters · filed 2019-11-07 | -$19.72M 10-Q · filed 2019-11-07 | -$2.96M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-06-30 | -$48.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$27.72M 10-Q · filed 2019-08-07 | -$10.96M derived: sum of 3 quarters · filed 2020-03-11 | $31.00M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-03-31 | $20.59M 10-Q · filed 2019-05-02 | $37.35M derived: sum of 2 quarters · filed 2020-03-11 | $79.31M derived: sum of 3 quarters · filed 2020-03-11 | $81.84M derived: sum of 4 quarters · filed 2020-03-11 |
| 2017-12-31 | $16.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $58.72M derived: sum of 2 quarters · filed 2020-03-11 | $61.25M derived: sum of 3 quarters · filed 2020-03-11 | $35.97M 10-K · filed 2020-03-11 |
| 2017-09-30 | $41.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $44.49M derived: sum of 2 quarters · filed 2018-11-07 | $19.20M 10-Q · filed 2018-11-07 | $105.11M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$22.75M 10-Q · filed 2018-08-08 | $63.15M derived: sum of 3 quarters · filed 2019-03-18 | |
| 2017-03-31 | -$25.28M 10-Q · filed 2018-05-09 | $60.62M derived: sum of 2 quarters · filed 2019-03-18 | ||
| 2016-12-31 | $85.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $28.02M 10-K · filed 2019-03-18 | ||
| 2016-09-30 | -$57.89M 10-Q · filed 2017-11-07 | |||
| 2015-12-31 | -$21.27M 10-K · filed 2018-03-14 | |||
| 2014-03-31 | $9.70M 10-Q · filed 2014-05-08 | |||
| 2013-09-30 | $15.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $12.21M derived: sum of 2 quarters · filed 2013-11-12 | $7.23M 10-Q · filed 2013-11-12 | -$9.88M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$8.18M 10-Q · filed 2013-08-08 | -$25.30M derived: sum of 3 quarters · filed 2014-05-08 | -$32.65M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-03-31 | -$4.97M 10-Q · filed 2014-05-08 | -$22.09M derived: sum of 2 quarters · filed 2014-05-08 | -$29.44M derived: sum of 3 quarters · filed 2014-05-08 | -$33.97M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | -$17.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$24.46M derived: sum of 2 quarters · filed 2013-11-12 | -$28.99M derived: sum of 3 quarters · filed 2013-11-12 | -$32.26M 10-K · filed 2013-03-12 |
| 2012-09-30 | -$7.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$11.88M derived: sum of 2 quarters · filed 2013-11-12 | -$15.15M 10-Q · filed 2013-11-12 | -$14.34M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | -$4.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$7.80M 10-Q · filed 2013-08-08 | -$6.99M derived: sum of 3 quarters · filed 2013-08-08 | -$3.37M derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | -$3.27M 10-Q · filed 2013-05-09 | -$2.47M derived: sum of 2 quarters · filed 2013-05-09 | $1.16M derived: sum of 3 quarters · filed 2013-05-09 | $7.29M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $4.43M derived: sum of 2 quarters · filed 2013-03-12 | $10.56M derived: sum of 3 quarters · filed 2013-03-12 | $18.54M 10-K · filed 2013-03-12 |
| 2011-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $9.75M derived: sum of 2 quarters · filed 2012-11-09 | $17.74M 10-Q · filed 2012-11-09 | $14.44M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $6.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $14.12M 10-Q · filed 2012-08-09 | $10.81M derived: sum of 3 quarters · filed 2013-03-12 | $6.85M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $7.99M 10-Q · filed 2012-05-09 | $4.68M derived: sum of 2 quarters · filed 2013-03-12 | $723.00K derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$7.26M derived: sum of 2 quarters · filed 2013-03-12 | -$21.27M 10-K · filed 2013-03-12 | |
| 2010-09-30 | -$3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$17.97M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$14.01M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $2.35M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |